Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Symptom experience of adverse drug reaction among male and female patients with newly diagnosed pulmonary tuberculosis in Thailand

Belitung Nursing Journal · Vol. 7 No. 3 (2021) · hlm. 195–202

DOI
10.33546/bnj.1337
ISSN
2477-4073, 2528-181X
Terbit
2021-05-14
Penerbit
Belitung Raya Publisher
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

Background: Patients with newly diagnosed pulmonary tuberculosis often suffer from adverse drug reaction symptoms, which leads to the automatic discontinuation of anti-tuberculosis drugs. Thus, understanding symptom experience of adverse drug reactions is necessary. Objective: This study aimed to examine differences in symptoms experienced in four dimensions: presence, frequency, severity, and distress of adverse drug reactions, between male and female patients. Methods: This was a quantitative survey with a cross-sectional design, with data collected between January and April 2020. A total of 394 patients with newly diagnosed pulmonary tuberculosis was selected through a purposive sampling technique. The symptom experiences of adverse drug reactions were measured using a validated instrument. Data were analyzed using mean, standard deviation, and independent t-test. Results: The most commonly reported symptom was itchiness (24.1% in males and 34.9% in females). Vomiting occurred as the most frequent symptom among males (x̅ ± SD = 2.73 ±.88), and fatigue was found to be the most severe and distressing symptom across male patients (x̅ ± SD = 2.50 ± 1.61 and 2.06 ± 1.30, respectively). In contrast, yellowing of the eyes and skin was most frequent and severe among females (x̅ ± SD = 3.17 ±.75 and 3.83 ± 1.47, respectively). In addition, flu-like symptoms were evaluated as the most distressing symptom for female patients (x̅ ± SD = 2.80 ± 1.09). The symptom burdens of the females ranged significantly and reached higher than those of the male patients at a p-value of.05 (t = 3.33). Conclusion: Females taking anti-tuberculosis drugs should be carefully monitored to deal with adverse drug reaction symptoms. This finding would help to decrease the severity of disease and improve their quality of life. Funding: This study received funding from the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University, Bangkok, Thailand (GCUGR1125633058M).

Kata kunci

Jaringan kolaborasi para penulis

18 penulis · 41 tautan kepenulisan bersama · 21 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Chulalongkorn University
  • Kementerian Kesehatan Republik Indonesia
  • University of Buraimi
  • STIKes Wira Medika Bali
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Yupin AungsurochChulalongkorn University3
Abdulkareem S. IblasiUniversity of Buraimi1
I Gede JuanamastaSTIKes Wira Medika Bali1
I Dewa Putu Gede Putra YasaKementerian Kesehatan Republik Indonesia1
I Wayan SurastaKementerian Kesehatan Republik Indonesia1
IGA Ari RasdiniKementerian Kesehatan Republik Indonesia1
Joko GunawanChulalongkorn University1
Sakuntala AnuruangChulalongkorn University1
Sitha PhongphiboolChulalongkorn University1
Nazliansyah NazliansyahKementerian Kesehatan Republik Indonesia1
Sudarat TippinitChulalongkorn University1
Kritphummarin ChongopklangChulalongkorn University1
Napassawan LungkawongChulalongkorn University1
Ampika InyooChulalongkorn University1
Pannawit MoonkaewChulalongkorn University1
Ratchadaporn BoonsanongChulalongkorn University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210240190, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Symptom experience of adverse drug reaction among male and female patients with newly diagnosed pulmonary tuberculosis in Thailand</dc:title><dc:creator>Apichaya Thontham</dc:creator><dc:creator>Rapin Polsook</dc:creator><dc:subject>adverse drug reactions</dc:subject><dc:subject>pulmonary tuberculosis</dc:subject><dc:subject>antitubercular agents</dc:subject><dc:subject>symptom experience</dc:subject><dc:subject>sex differences</dc:subject><dc:subject>symptom burden</dc:subject><dc:subject>pruritus</dc:subject><dc:subject>vomiting</dc:subject><dc:subject>fatigue</dc:subject><dc:subject>jaundice</dc:subject><dc:subject>flu-like symptoms</dc:subject><dc:subject>drug discontinuation</dc:subject><dc:subject>Thailand</dc:subject><dc:description xml:lang="en">Background: Patients with newly diagnosed pulmonary tuberculosis often suffer from adverse drug reaction symptoms, which leads to the automatic discontinuation of anti-tuberculosis drugs. Thus, understanding symptom experience of adverse drug reactions is necessary. Objective: This study aimed to examine differences in symptoms experienced in four dimensions: presence, frequency, severity, and distress of adverse drug reactions, between male and female patients. Methods: This was a quantitative survey with a cross-sectional design, with data collected between January and April 2020. A total of 394 patients with newly diagnosed pulmonary tuberculosis was selected through a purposive sampling technique. The symptom experiences of adverse drug reactions were measured using a validated instrument. Data were analyzed using mean, standard deviation, and independent t-test. Results: The most commonly reported symptom was itchiness (24.1% in males and 34.9% in females). Vomiting occurred as the most frequent symptom among males (x̅ ± SD = 2.73 ± .88), and fatigue was found to be the most severe and distressing symptom across male patients (x̅ ± SD = 2.50 ± 1.61 and 2.06 ± 1.30, respectively). In contrast, yellowing of the eyes and skin was most frequent and severe among females (x̅ ± SD = 3.17 ± .75 and 3.83 ± 1.47, respectively). In addition, flu-like symptoms were evaluated as the most distressing symptom for female patients (x̅ ± SD = 2.80 ± 1.09). The symptom burdens of the females ranged significantly and reached higher than those of the male patients at a p-value of .05 (t = 3.33). Conclusion: Females taking anti-tuberculosis drugs should be carefully monitored to deal with adverse drug reaction symptoms. This finding would help to decrease the severity of disease and improve their quality of life. Funding: This study received funding from the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University, Bangkok, Thailand (GCUGR1125633058M).</dc:description><dc:publisher>Belitung Raya Publisher</dc:publisher><dc:date>2021-05-14</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.33546/bnj.1337</dc:identifier><dc:identifier>10.33546/bnj.1337</dc:identifier><dc:source>Belitung Nursing Journal; Vol 7 No 3 (2021); 195-202</dc:source><dc:source>2477-4073</dc:source><dc:source>2528-181X</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>